CHICAGO (Reuters) Jan 22 - Stryker Corp said on Tuesday it is
recalling some artificial hip products made at its Cork, Ireland,
facility because the devices did not meet company manufacturing
standards.
The orthopedic device maker said it is voluntarily recalling the
Trident PSL hip implant components and Hemispherical Acetabular Cups
because tests revealed the level of manufacturing "residuals"
sometimes exceeded company standards.
It said it does not believe the products pose a safety risk to
patients, and noted the devices meet U.S. and international standards
for sterility and compatibility in the human body.
Stryker said it conducted the tests after the U.S. Food and Drug
Administration in November warned the company about manufacturing
problems linked to malfunctioning hip parts.
The company has validated the manufacturing process for the
acetabular cups in Cork and resumed shipment of those products while
increasing production at both its Cork and Mahwah, New Jersey,
facilities.
The FDA in its November warning letter to Stryker cited quality
problems in manufacturing processes at the Mahwah facility and said
it had received complaints that some Trident hip components failed to
function, causing some patients to need additional surgery.
The FDA sent Stryker a separate warning letter last March, citing the
company's failure to remedy quality problems at the Cork plant.